Efficacy and safety of SARS-CoV-2 vaccination in pregnancy to prevent COVID-19 in mothers and early infancy

Odette de Bruin*, Emily Wem Phijffer, Fariba Ahmadizar, Nicoline At Van der Maas, Joanne G Wildenbeest, Miriam Cjm Sturkenboom, Louis J Bont, Carlos E Durán, Kitty Wm Bloemenkamp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of SARS-CoV-2 vaccination during pregnancy, versus placebo or no vaccination during pregnancy, for preventing COVID-19 disease in mothers and infants.

Original languageEnglish
Article numberCD015785
Pages (from-to)1-12
Number of pages12
JournalThe Cochrane database of systematic reviews
Volume2025
Issue number2
DOIs
Publication statusPublished - 26 Feb 2025

Keywords

  • COVID-19 Vaccines/administration & dosage
  • COVID-19/prevention & control
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Complications, Infectious/prevention & control
  • Randomized Controlled Trials as Topic
  • SARS-CoV-2/immunology
  • Vaccination

Fingerprint

Dive into the research topics of 'Efficacy and safety of SARS-CoV-2 vaccination in pregnancy to prevent COVID-19 in mothers and early infancy'. Together they form a unique fingerprint.

Cite this